TrialClinical pharmacokinetics2019
Intra-monocyte Pharmacokinetics of Imiglucerase Supports a Possible Personalized Management of Gaucher Disease Type 1.
Juliette Berger et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it